Literature DB >> 21236253

Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).

Nadarajah Vigneswaran1, Jean Wu, Anren Song, Ananth Annapragada, Wolfgang Zacharias.   

Abstract

Hypoxia confers resistance to chemoradiation therapy and promotes metastasis in head and neck squamous cell carcinomas (HNSCC). We investigated the effects of hypoxia in tumor phenotype using immunocompetent murine HNSCC models. Balb/c mice were injected intraorally with murine squamous cell carcinoma cells LY-2 and B4B8. Intratumoral hypoxia fraction was evaluated by the immunohistochemical detection of hypoxic probe pimonidazole and carbonic anhydrase IX (CAIX). Tumor cell apoptosis and autophagy in hypoxic areas of these tumors were examined immunohistochemically. Hypoxia-induced apoptotic and autophagic responses in vitro were examined by treating LY2 cells with CoCl(2). B4B8 tumors exhibited a non-aggressive phenotype characterized by its slow growth rate and the lack of metastatic spread. LY2 tumors demonstrated an aggressive phenotype characterized by rapid growth rate with regional and distant metastasis. Intratumoral hypoxia fraction in B4B8 tumors was significantly lower than in LY2 tumors. The hypoxic areas in B4B8 tumors exhibited increased apoptosis rate than that of LY2 tumors. In contrast, the hypoxic areas in LY2 tumors revealed autophagy. The induction of hypoxia in vitro elicited autophagy and not apoptosis in LY2 cells. The induction of autophagy coupled with blockage of apoptosis in hypoxic areas promotes tumor cell survival and confers aggressive phenotype in immunocompetent murine HNSCC models.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236253      PMCID: PMC3057178          DOI: 10.1016/j.yexmp.2010.11.011

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  84 in total

Review 1.  Targeting hypoxia in head and neck cancer.

Authors:  L J Peters
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

2.  Orally administered pimonidazole to label hypoxic tumor cells.

Authors:  Kevin L Bennewith; James A Raleigh; Ralph E Durand
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

3.  Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia.

Authors:  Nobuhito Goda; Heather E Ryan; Bahram Khadivi; Wayne McNulty; Robert C Rickert; Randall S Johnson
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 4.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

5.  A cervical lymph node metastatic model of human tongue carcinoma: Serial and orthotopic transplantation of histologically intact patient specimens in nude mice.

Authors:  Cunping Qiu; Hong Wu; Huajun He; Weiliu Qiu
Journal:  J Oral Maxillofac Surg       Date:  2003-06       Impact factor: 1.895

Review 6.  Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?

Authors:  Dirk Vordermark; J Martin Brown
Journal:  Strahlenther Onkol       Date:  2003-12       Impact factor: 3.621

7.  Chronic hypoxia protects against gamma-irradiation-induced apoptosis by inducing bcl-2 up-regulation and inhibiting mitochondrial translocation and conformational change of bax protein.

Authors:  Olivier Cuisnier; Raphael Serduc; Jean-Pierre Lavieille; Michel Longuet; Emile Reyt; Catherine Riva
Journal:  Int J Oncol       Date:  2003-10       Impact factor: 5.650

Review 8.  The hypoxic tumour microenvironment and metastatic progression.

Authors:  Patrick Subarsky; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Authors:  Xueping Qu; Jie Yu; Govind Bhagat; Norihiko Furuya; Hanina Hibshoosh; Andrea Troxel; Jeffrey Rosen; Eeva-Liisa Eskelinen; Noboru Mizushima; Yoshinori Ohsumi; Giorgio Cattoretti; Beth Levine
Journal:  J Clin Invest       Date:  2003-11-24       Impact factor: 14.808

10.  Hypoxia and CoCl2 protect HepG2 cells against serum deprivation- and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1.

Authors:  Jean-Pascal Piret; Christophe Lecocq; Sebastien Toffoli; Noelle Ninane; Martine Raes; Carine Michiels
Journal:  Exp Cell Res       Date:  2004-05-01       Impact factor: 3.905

View more
  12 in total

1.  STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma.

Authors:  Nathan Ryan; Kelvin Anderson; Greta Volpedo; Omar Hamza; Sanjay Varikuti; Abhay R Satoskar; Steve Oghumu
Journal:  Int J Cancer       Date:  2019-11-29       Impact factor: 7.396

2.  Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B.

Authors:  Pamela D Thompson; Amos Sakwe; Rainelli Koumangoye; Wendell G Yarbrough; Josiah Ochieng; Dana R Marshall
Journal:  Exp Cell Res       Date:  2013-12-12       Impact factor: 3.905

3.  Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phosphorylation-mediated TRAIL expression in head and neck squamous carcinoma FaDu cells.

Authors:  Mi-Ra Park; Su-Gwan Kim; In-A Cho; Dahye Oh; Kyeong-Rok Kang; Sook-Young Lee; Sung-Min Moon; Seung Sik Cho; Goo Yoon; Chun Sung Kim; Ji-Su Oh; Jae-Seek You; Do Kyung Kim; Yo-Seob Seo; Hee-Jeong Im; Jae-Sung Kim
Journal:  Food Chem Toxicol       Date:  2015-01-05       Impact factor: 6.023

4.  Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma.

Authors:  Alexander A Strait; Rachel A Woolaver; Spencer C Hall; Christian D Young; Sana D Karam; Antonio Jimeno; Yan Lan; David Raben; Jing H Wang; Xiao-Jing Wang
Journal:  Commun Biol       Date:  2021-08-25

5.  Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response.

Authors:  Anika Nagelkerke; Johan Bussink; Hilda Mujcic; Bradly G Wouters; Steffi Lehmann; Fred C G J Sweep; Paul N Span
Journal:  Breast Cancer Res       Date:  2013-01-07       Impact factor: 6.466

6.  miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo.

Authors:  Li-Yin Yeh; Chung-Ji Liu; Yong-Kie Wong; Christine Chang; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Oncotarget       Date:  2015-03-20

7.  II. Capsular vaso-mimicry formed by transgenic mammary tumor spheroids implanted ectopically into mouse dorsal skin fold: implications for cellular mechanisms of metastasis.

Authors:  Halina Witkiewicz; Phil Oh; Jan E Schnitzer
Journal:  F1000Res       Date:  2013-01-10

8.  Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal.

Authors:  Xiteng Yin; Zheng Wei; Chuanhui Song; Chuanchao Tang; Wenguang Xu; Yufeng Wang; Junqi Xie; Zitong Lin; Wei Han
Journal:  Cancer Manag Res       Date:  2018-11-19       Impact factor: 3.989

9.  Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB.

Authors:  Faranak Mahjour; Vrinda Dambal; Neha Shrestha; Varun Singh; Vikki Noonan; Alpdogan Kantarci; Philip C Trackman
Journal:  Oncogenesis       Date:  2019-05-13       Impact factor: 7.485

10.  Chloroquine promotes the anticancer effect of TACE in a rabbit VX2 liver tumor model.

Authors:  Lu Gao; Jian-rui Song; Jian-wei Zhang; Xue Zhao; Qiu-dong Zhao; Kai Sun; Wei-jie Deng; Rong Li; Gang Lv; Hong-yan Cheng; Li-xin Wei
Journal:  Int J Biol Sci       Date:  2013-03-28       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.